Literature DB >> 1260718

Thyroid cancer: a study of 573 thyroid tumors and 161 autopsy cases observed over a thirty-year period.

P Heitz, H Moser, J J Staub.   

Abstract

Five hundred and seventy-three thyroid tumors from surgical material and 161 autopsy cases were studied as to incidence, types, and precursor changes using the new WHO-classification. In the surgical material 225 tumors were follicular, 145 papillary, 147 anaplastic, 23 squamous cell, and 10 medullary. Twenty-three sarcomas were found. tthe percentage of follicular carcinoma had decreased, whereas that of papillary carcinoma increased and that of anaplastic carcinoma remained constant. In over 50% of anaplastic carcinomas neoplastic follicular structures have been identified. As a rule the more sections are prepared, the more papillary carcinomas and the less sarcomas are diagnosed. Thyroid tumors leading to death were found in 0.33% of 53,134 consecutive autopsies. Anaplastic (52.3%) and follicular (33.5%) carcinoma were most frequently encountered. Metastases of follicular and anaplastic carcinoma were most often found in the lung, pleura, and bones, whereas lymph nodes of the neck, lung, and bones were predominantly involved in cases of the papillary type. Therapy of thyroid carcinoma is total thyroidectomy. The transition of follicular carcinoma to the anaplastic type has to be avoided whenever possible.

Entities:  

Mesh:

Year:  1976        PMID: 1260718     DOI: 10.1002/1097-0142(197605)37:5<2329::aid-cncr2820370523>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006.

Authors:  Oladejo Olaleye; Udeme Ekrikpo; Ram Moorthy; Owen Lyne; Jill Wiseberg; Myles Black; David Mitchell
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-12       Impact factor: 2.503

2.  Evidence of vascular differentiation in anaplastic tumours of the thyroid--an immunohistological study.

Authors:  F Eckert; U Schmid; F Gloor; C Hedinger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 3.  Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model.

Authors:  H Rubén Harach; Gustavo A Ceballos
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Multimodal therapy in anaplastic giant cell thyroid carcinoma.

Authors:  B Werner; J Abele; A Alveryd; A Björklund; S Franzén; P O Granberg; T Landberg; G Lundell; T Löwhagen; R Sundblad
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

5.  T3 toxicosis due to nonmetastatic follicular carcinoma of the thyroid.

Authors:  A Pont; D Spratt; J B Shinn
Journal:  West J Med       Date:  1982-03

6.  [Thyroid carcinoma in the bavarian endemic goiter area (author's transl)].

Authors:  U Löhrs; W Permanetter; F Spelsberg; M Beitinger
Journal:  Klin Wochenschr       Date:  1980-04-15

7.  In vitro and in vivo characterizations of established human follicular carcinoma cell line derived from thyroid cancer: a novel model for well-differentiated thyroid malignant tumor.

Authors:  T Tsuda
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

8.  Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis.

Authors:  H Rubén Harach; Dardo A Escalante; Ernesto Saravia Day
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 9.  Solitary liver metastasis from Hürthle cell thyroid cancer: a case report and review of the literature.

Authors:  M Salvatori; G Perotti; V Rufini; M L Maussier; V Summaria; G Fadda; L Troncone
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

10.  Clinical Status and Treatment of Liver Metastasis of Differentiated Thyroid Cancer Using Tyrosine Kinase Inhibitors.

Authors:  Yoshiyuki Saito; Kiminori Sugino; Hiroshi Takami; Kenichi Matsuzu; Takashi Uruno; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Hirofumi Kawakubo; Koichi Ito; Yuko Kitagawa
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.